Cargando…

Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions

Therapeutic monoclonal antibodies (mAbs) such as antibody–drug conjugates, ligand–receptor antagonists, immune checkpoint inhibitors and bispecific T cell engagers have shown impressive efficacy in the treatment of multiple human cancers. Numerous therapeutic mAbs that have been developed for myeloi...

Descripción completa

Detalles Bibliográficos
Autor principal: Schürch, Christian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968093/
https://www.ncbi.nlm.nih.gov/pubmed/29868474
http://dx.doi.org/10.3389/fonc.2018.00152